As CMS ploughs through the 200-day moving average, it does not seem to be inclined to take prisoners, so the 12,000,000 shorts may have an interesting ride. Most of the new money seems to be long-term buying, so the shares may have a good chance to recoup some of the huge decline from just a year ago. [$18.54 on May 28]. Anyway, we're back to book value and the guidance has been reaffirmed, so hang on for a nice ride. JMHO.